Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vasoconstriction is the physiological process in which blood vessels narrow due to the contraction of smooth muscle cells in their walls. This narrowing reduces the diameter (lumen) of the vessel, leading to decreased blood flow and increased vascular resistance. It is a critical mechanism for regulating blood pressure, redistributing blood flow, conserving body heat, and responding to various stimuli such as cold temperatures or stress.
Contraction of vascular smooth muscle cells triggered by an increase in intracellular calcium concentration. Calcium enters via voltage-gated channels or is released from intracellular stores (sarcoplasmic reticulum) through IP3-mediated pathways. Calcium binds calmodulin, activating myosin light-chain kinase (MLCK), which phosphorylates myosin light chains and initiates cross-bridge cycling with actin filaments—resulting in contraction.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vasoconstriction.